ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors
dc.contributor.author | Jadhav, Vinod D. | |
dc.contributor.author | Duerfeldt, Adam S. | |
dc.contributor.author | Blagg, Brian S. J. | |
dc.date.accessioned | 2017-05-03T20:42:20Z | |
dc.date.available | 2017-05-03T20:42:20Z | |
dc.date.issued | 2009-12-15 | |
dc.identifier.citation | Jadhav, V. D., Duerfeldt, A. S., & Blagg, B. S. J. (2009). Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors. Bioorganic & Medicinal Chemistry Letters, 19(24), 6845–6850. http://doi.org/10.1016/j.bmcl.2009.10.091 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23882 | |
dc.description.abstract | Bicyclic radester analogues have been synthesized and evaluated for Hsp90 inhibitory activity. These analogues induce concentration-dependent degradation of Hsp90-dependent client proteins with the six-membered bicyclic analogues manifesting increased activity versus the five-membered counterparts. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This article is made available under an Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) License. | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ | en_US |
dc.subject | Hsp90 | en_US |
dc.subject | Geldanamycin | en_US |
dc.subject | Radicicol | en_US |
dc.subject | Anti-cancer | en_US |
dc.title | Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Jadhav, Vinod D. | |
kusw.kuauthor | Duerfeldt, Adam S. | |
kusw.kuauthor | Blagg, Brian S. J. | |
kusw.kudepartment | Medicinal Chemistry | en_US |
dc.identifier.doi | 10.1016/j.bmcl.2009.10.091 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-3130-9890 | |
dc.identifier.orcid | https://orcid.org/0000-0002-2918-6254 | |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC2784232 | en_US |
dc.rights.accessrights | openAccess |